Patents by Inventor Albert SICKMANN

Albert SICKMANN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for identifying marker proteins for the diagnosis and risk stratification of blood coagulation disorders
    Patent number: 10948496
    Abstract: The invention relates to a method for identifying marker proteins for the purpose of diagnosis and risk stratification of blood coagulation disorders.
    Type: Grant
    Filed: May 8, 2016
    Date of Patent: March 16, 2021
    Assignee: LEIBNIZ-INSTITUT FÜR ANALYTISCHE WISSENSCHAFTEN—ISAS—E.V.
    Inventors: Florian Beck, Albert Sickmann, Rene Zahedi
  • METHOD FOR IDENTIFYING MARKER PROTEINS FOR THE DIAGNOSIS AND RISK STRATIFICATION OF BLOOD COAGULATION DISORDERS
    Publication number: 20180136221
    Abstract: The invention relates to a method for identifying marker proteins for the purpose of diagnosis and risk stratification of blood coagulation disorders.
    Type: Application
    Filed: May 8, 2016
    Publication date: May 17, 2018
    Applicant: LEIBNIZ-INSTITUT FÜR ANALYTISCHE WISSENSCHAFTEN - ISAS - E.V.
    Inventors: Florian BECK, Albert SICKMANN, Rene ZAHEDI
  • Method for measurement of thrombocyte function
    Patent number: 9778248
    Abstract: With a method for measurement of thrombocyte function, a solution is created, by which the sensitivity of individual thrombocytes can be measured with the least possible apparatus effort, with high throughput, by passing a liquid thrombocyte solution, in which the thrombocytes are present in isolated form, into a microfluidic chamber and brought into contact with at least one stimulant, wherein an electrical field directed transverse to the entry direction of the thrombocyte solution is applied to the chamber, and the movement path of the thrombocytes in the electrical field is observed and evaluated, in such a manner that thrombocytes having a movement path directed in the direction toward the minus pole of the electrical field are classified as non-activated thrombocytes, and thrombocytes having a movement path directed in the direction toward the plus pole of the electrical field are classified as activated thrombocytes.
    Type: Grant
    Filed: August 26, 2015
    Date of Patent: October 3, 2017
    Assignee: Leibniz—Institut fuer Analytische Wissenschaften—ISAS—e.V.
    Inventors: Jonathan West, Dirk Janasek, Albert Sickmann
  • METHOD FOR MEASUREMENT OF THROMBOCYTE FUNCTION
    Publication number: 20160061819
    Abstract: With a method for measurement of thrombocyte function, a solution is created, by which the sensitivity of individual thrombocytes can be measured with the least possible apparatus effort, with high throughput, by passing a liquid thrombocyte solution, in which the thrombocytes are present in isolated form, into a microfluidic chamber and brought into contact with at least one stimulant, wherein an electrical field directed transverse to the entry direction of the thrombocyte solution is applied to the chamber, and the movement path of the thrombocytes in the electrical field is observed and evaluated, in such a manner that thrombocytes having a movement path directed in the direction toward the minus pole of the electrical field are classified as non-activated thrombocytes, and thrombocytes having a movement path directed in the direction toward the plus pole of the electrical field are classified as activated thrombocytes.
    Type: Application
    Filed: August 26, 2015
    Publication date: March 3, 2016
    Applicant: Leibniz - Institut fuer Analytische Wissenschaften - ISAS - e.V.
    Inventors: Jonathan WEST, Dirk JANASEK, Albert SICKMANN